Related Experiment Video
Updated: Jul 16, 2026

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
A case of oxaliplatin-related posterior reversible encephalopathy syndrome
Matthew R Skelton1, Richard M Goldberg, Bert H O'Neil
1Division of Hematology and Oncology, University of North Carolina at Chapel Hill, NC 27599-7305, USA.
Abstract:
We report the first case of oxaliplatin-related posterior reversible encephalopathy syndrome (PRES) in the medical literature. A 19-year-old woman with metastatic adenocarcinoma of the rectum received modified FOLFOX (5-fluorouracil/oxaliplatin) chemotherapy. Ten days after the fourth treatment, she presented to the hospital with seizures and altered mental status. Magnetic resonance imaging of the brain demonstrated hyperintensity in the white matter of the posterior hemispheres consistent with PRES. Herein, we briefly review the PRES syndrome and its management.
Related Concept Videos
Hepatic Encephalopathy
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Drug toxicity: Idiosyncratic Reactions
Drug Toxicity: Risk factors
Encephalitis l: Introduction
Pharmaceutical Poisoning: Potential Scenarios